Want to join the conversation?
$ROP said it maintained its guidance for full year 2016 adjusted diluted EPS of $6.85-7.15. The company expects 2Q16 adjusted diluted EPS to be $1.56-1.61. $ROP stated that its guidance excludes the impact of any future acquisitions or divestitures.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?